Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug

International Journal of Drug Policy

Volumn 19, Issue SUPPL. 1, 2008, Pages 47-58

  Tempalski, Barbara ^a,d   Cooper, Hannah L ^b,d   Friedman, Samuel R ^a,c,d   Des Jarlais, Don C ^a,c,d   Brady, Joanne ^a   Gostnell, Karla ^a,d  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b EMORY UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Coverage; Government funding; Grassroots activism; Heroin injection events; Syringe exchange programmes

Indexed keywords

DIAMORPHINE;

ARTICLE; BIVARIATE ANALYSIS; FUNDING; HEALTH PROGRAM; HEALTH SURVEY; HEROIN DEPENDENCE; PRIORITY JOURNAL; SOCIOECONOMICS; SYRINGE;

FINANCING, GOVERNMENT; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; NEEDLE-EXCHANGE PROGRAMS; POLITICS; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; UNITED STATES;

EID: 41149178974     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2007.11.011     Document Type: Article

References (65)

1. ACT-UP (2003). From http://www.actupny.org/indexfolder/links.html. 2003.
2. American Bar Association (ABA) (2001). AIDS Coordinating Committee. Deregulation of hypodermic needles and syringes as a public health measure: A report on emerging policy and law in the United States. AIDS Coordination Project.
3. Beth Israel Medical Center. Beth Israel National Syringe Exchange Survey (2000), BINSES
4. Bluthenthal R.N., Kral A.H., Lorvick J., and Watters J.K. Impact of law enforcement on syringe exchange programs: A look at Oakland and San Francisco. Medical Anthropology 18 (1997) 61-83
5. Bluthenthal R.N., Kral A.H., Erringer E.A., and Edlin B.R. Drug paraphernalia laws and injection-related infectious disease risk among drug injectors. Drug Issues 22 (1999) 1-16
6. Bluthenthal R.N., Lorvick J., Kral A.H., Erringer E.A., and Kahn J.G. Collateral damage in the war on drugs: HIV risk behaviors among injection drug users. International Journal of Drug Policy 10 (1999) 25-38
7. Bluthenthal R.N., Anderson R., Flynn N.M., and Kral A.H. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence 89 (2007) 214-222
8. Bluthenthal R.N., Ridgeway G., Schell T., Anderson R., Flynn N.M., and Kral A.H. Does syringe dispensation policy matter? Examining association between syringe coverage and dispensation policy among SEP clients. Addiction 102 (2007) 638-646
9. Brown B.S., and Beschner G.M. Introduction. In: Brown B.S., and Beschner G.M. (Eds). with The National AIDS Research Consortium. Handbook on risk of AIDS: injection drug use and sexual partners (1993), Greenwood Press, Westport, CT
10. Brown P., Zavestoski S., McCormick S., Mayer B., Morello-Frosch R., and Gasior R. Embodied health movements: New approaches to social movements in health. Sociology of Health and Illness 26 (2004) 50-80
11. Buchanan D., Tooze J.A., Shaw S., Kinzly M.L., Heimer R., and Singer M. Demographic, HIV risk behavior, and health status characteristics of "crack" cocaine injectors compared to other injection drug users in three New England cities. Drug and Alcohol Dependence 8 (2006) 221-229
12. Burawoy M. Ethnography unbound: Power and resistance in the modern metropolis (1991), University of California Press
13. Burris S., Vernick J., Ditzler A., and Strathdee S. The legality of selling or giving syringes to injection drug users. In: Jones T.S., and Coffin P.O. (Eds). Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal Vol. 42 (2002), Journal of the American Pharmaceutical Association S13-S17 Suppl. 2
14. Centers for Disease Control and Prevention (2003). AIDS public information data set.
15. Centers for Disease Control and Prevention, Health Resources & Services Administration, National Institute on Drug Abuse of the National Institutes of Health, and the Center for Substance Abuse Treatment of the Substance Abuse and Mental Health Services Administration (1997). HIV prevention bulletin: Medical advice for persons who inject illicit drugs. From http://www.cdc.gov/idu/pubs/hiv_prev.htm.
16. Cooper H., Moore L., Gruskin S., and Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: A qualitative study. Social Science and Medicine 61 (2005) 673-684
17. Des Jarlais D.C., Friedman S.R., Casriel C., and Kott A. AIDS and preventing initiation into intravenous (IV) drug use. Psychology and Health 1 (1987) 141-179
18. Des Jarlais D.C. Research, politics, and needle exchange. American Journal of Public Health 90 9 (2000) 1392-1394
19. Des Jarlais D.C., McKnight C., and Milliken J. Public funding of U.S. syringe exchange programs. Journal of Urban Health: Bulletin of the New York Academy of Medicine 18 (2004) 118-121
20. Des Jarlais D.C., Paone D., Friedman S.R., Peyser N., and Newman R.G. Public health then and now: Regulating controversial programs for unpopular people: Methadone maintenance and syringe-exchange programs. American Journal of Public Health 85 (1995) 1577-1584
21. Des Jarlais D.C., Perlis T., Arasteh K., Torian L.V., Beatrice S., Milliken J., et al. HIV incidence among injecting drug users in New York City, 1990 to 2002: Use of serologic test algorithm to assess expansion of HIV prevention services. American Journal of Public Health 95 (2005) 1439-1444
22. Des Jarlais D.C., Friedman S.R., and Burrows D. Coverage of harm reduction programs. Proceedings of the APMG Satellite Session on coverage of harm reduction programmes at the 17th international conference on the reduction of drug-related harm. Vancouver (2006 (May))
23. Epstein S. Impure science: AIDS, activism, and the politics of knowledge (1996), University of California Press, Berkeley, CA
24. Federal Bureau of Investigation (1993). U.S. Dept. of Justice, Uniform crime reporting program data: Police employee (LEOKA) data, 1993.
25. Federal Bureau of Investigation (1993). U.S. Dept. of Justice, Uniform crime reporting program data: County-level detailed arrest and offense data, 1993.
26. Fischer B., and Poland B. Exclusion, "risk, " and social control: Reflections on community policing and public health. Geoforum 29 (1998) 187-197
27. Friedman S.R., Tempalski B., Cooper H., Perlis T., Keem M., Friedman R., et al. Estimating numbers of IDUs in metropolitan areas for structural analyses of community vulnerability and for assessing relative degrees of service provision for IDUs. Journal of Urban Health 8 (2004) 377-400
28. Friedman S.R., Perlis T., and Des Jarlais D.C. Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health 91 (2001) 791-793
29. Friedman S.R., Cooper H.L., Tempalski B., Keem M., Friedman R., Flom P.L., et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in U.S. metropolitan areas. AIDS 20 (2006) 93-99
30. Galai N., Safaeian M., Vlahov D., Bolotin A., and Celentano D.D. Longitudinal patterns of drug injection behaviour in the ALIVE study cohort, 1988-2000: Description and determinants. American Journal of Epidemiology 158 (2003) 695-704
31. Galston, W. A. (n.d.). Civic education and political participation. Institute for Philosophy and Public Policy, University of Maryland.
32. Holmberg S. The estimated prevalence and incidence of HIV in 41 large U.S. metropolitan areas. American Journal of Public Health 86 (1996) 642-654
33. Holtgrave D.R., Pinkerton S.D., Jones T.S., Lurie P., and Vlahov D. Cost and cost-effectiveness of increasing access to sterile syringes and needles as a HIV prevention intervention in the United States. Journal of Acquired Immuno-deficiency Syndromes and Human Retro Virology 18 Suppl. 1 (1988) S133-S138
34. Hagan H., Thiede H., and Des Jarlais D.C. HIV/hepatitis C virus co-infection in drug users: Risk behaviour and prevention. AIDS 19 Supp 3 (2005) S199-S207
35. Hagan H., McGough J.P., Thiede H., Hopkins S., Duchin J., and Alexander E.R. Reduced injection frequency and increased entry and retention in drug treatment associated with needle exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment 19 (2000) 247-252
36. Heimer R. The range of community coverage by syringe exchange programmes in the United States. Proceedings of the APMG Satellite Session on coverage of harm reduction programmes at the 17th international conference on the reduction of drug-related harm. Vancouver (2006 (May))
37. Hurley S.F., Jolley D.J., and Kaldor J.M. Effectiveness of needle-exchange programmes for prevention of HIV infection. The Lancet 21 (1997) 1797-1800
38. Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) (2006). AIDS epidemic update: special report on the Global AIDS Epidemic: December 2006.
39. Laufer N.F. Cost-effectiveness of syringe exchange as an HIV prevention strategy. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 28 (2001) 273-278
40. Latkin C.A., Davey M.A., and Hua W. Social context of needle selling in Baltimore, Maryland. Substance Use & Misuse 41 (2006) 901-913
41. Lurie P., and Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programmes in the USA. The Lancet 349 (1997) 604-608
42. Luire P., Jones T.S., and Foley J. A sterile syringe for every drug user injection: How many injections take place annually, and how might pharmacists contribute to syringe distribution?. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18 Suppl. 1 (1998) S45-S51
43. McCampbell S.W., and Rubin P.N. A needle exchange program: what's in it for police?. Police Executive Research Forum (2000) 14
44. MacDonald M., Law M., Kaldor J., Hales J., and Dore G. Effectiveness of needle and syringe programmes for preventing HIV transmission. International Journal of Drug Policy 14 (2003) 351-352
45. Massard da Fonseca E., Mendes Ribeiro J., Bertoni N., and Bastod F.I. Syringe exchange programmes in Brazil: preliminary assessment of 45 programmes. Cadernos de Saúde Pública 22 (2006) 761-770
46. National Institutes of Drug Abuse (2001). Epidemiologic Trends in Drug Abuse Advance Report.
47. National Institutes of Health, National Institute on Drug Abuse, Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Programme (NIH/NIDA/COOP). (2001). Final analytical report: NIDA Cooperative Agreement Programme. Prepared for the National Institute on Drug Abuse: Centre on AIDS & Other Medical Consequences of Drug Abuse.
48. Novick D.M., Haverkos H.W., and Teller D.W. The medically ill substance abuser. In: Joyce H., Lowinson, Pedro Ruiz, Robert B., Millman, John G., and Landgrod (Eds). Substance abuse: A comprehensive textbook. 3rd Ed. (1997), Williams & Wilkins, Baltimore 534-550
49. Pallas A.M. The effects of schooling on individual lives. In: Hallinan M.T. (Ed). Handbook of the sociology of education (2000), Kluwer Academic/Plenum Publishers, Amsterdam 499-525
50. Pierce T. Gen-X junkie: Ethnographic research with young white heroin users in Washington, DC. Substance Use Misuse 34 (2003) 2095-2114
51. Remis R.S., Bruneau J., and Hankins C.A. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 18 Suppl. 1 (2003) S57-S59
52. Rhodes T., Mikhailova L., Sarang A., Lowndes C.M., Rylkov A., Khutorskoy M., et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti city. Russian Federation: a qualitative study of micro risk environment. Social Science and Medicine 57 (2003) 39-54
53. Sharma M., Burrows D., and Bluthenthal B. Coverage of HIV prevention programmes for injection drug users: Confusions, aspirations, definitions and ways forward. Commentary. International Journal of Drug Policy 18 (2007) 92-98
54. Singer M., Himmelgreen D., Dushay D., and Weeks M.R. Variation in drug injection frequency among out-of-treatment drug users in a national sample - The NIDA Cooperative Agreement for AIDS Community-Based Outreach/Intervention Research Programme - National Institute on Drug Abuse. American Journal of Drug and Alcohol Abuse (1998) 24
55. Stein M.D., and Anderson B. Injection frequency mediates health service use among persons with a history of drug injection. National Institutes of Health 70 (2003) 159-168
56. Substance Abuse and Mental Health Services Administration (SAMHSA) (2005). Treatment Episode Data Set (TEDS): Vol. 2000: Substance Abuse and Mental Health Services Administration.
57. Tempalski B., Flom P.L., Friedman S.R., Des Jarlais D.C., Friedman J.J., McKnight C., et al. Social and political factors predicting the presence of syringe exchange programs in 96 metropolitan areas in the United States. American Journal of Public Health 97 3 (2007) 437-447
58. Tempalski B. Placing the dynamics of syringe exchange programs in the United States. Health & Place 13 2 (2007) 417-431
59. Tempalski B., Friedman R., Keem M., Cooper H., and Friedman S.R. NIMBY localism and national inequitable exclusion alliances: The case of syringe exchange programs in the United States. Geoforum 38 (2007) 1250-1263
60. Tempalski, B., McKnight, C., Des Jarlais, D. C., Friedman, S. R., Burris, S. Spatial variations of legality, funding and services among Syringe Exchange Programs in the United States. Published abstract. XV International AIDS Conference. Bangkok, Thailand. July 11-16, 2004.
61. Lewis Mumford (1990). University at Albany, Lewis Mumford Centre for Comparative Urban and Regional Research. Race and residential segregation statistics.
62. United States Census Bureau (1990). Housing and Household Economic Statistics Division.
63. Vickerman P., Hickman M., Rhodes T., and Watts C. Model projections on the required coverage of syringe distribution to prevent HIV epidemics among injecting drug users. Journal of Acquired Immune Deficiency Syndromes 42 (2006) 355-361
64. Virginia Commonwealth University Centre for Public Policy. Public values science but wary of cloning, stem cell research (2002), Virginia Commonwealth University Life Sciences, Richmond, VA
65. Wallace R., and Wallace D. Socioeconomic determinants of health: Community marginalization and the diffusion of disease and disorder in the United States. British Medical Journal 314 (1997) 1341-1345